Pure Global
NCT06251674

Efficacy of Ultrasound-guided Transverse Carpal Ligament Release for Carpal Tunnel Syndrome

Comparison of Ultrasound-guided Transverse Carpal Ligament Needle Release Via Different Approaches for Patients With Mild-to-moderate Carpal Tunnel Syndrome
Peking University People's Hospital·ClinicalTrials.gov·otherCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Carpal Tunnel Syndrome
Drug/Device/Intervention
long-axis needle release
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Peking University People's Hospital
Location
Beijing, China
Timeline & enrollment
Phase
N/A
Start date
Jan 01, 2020
End date
Dec 30, 2023
Enrollment
60 participants
Primary outcome

visual analogue scale(VAS) scores

Summary

Carpal tunnel syndrome (CTS) is one of the most common peripheral nerve entrapment
 neuropathies, and it is characterized by pain, numbness, tingling, and weakness in the
 regions innervated by the median nerve (MN). CTS is believed to result from compression of
 the MN as it passes through the narrowed carpal tunnel with regard to gradual ischemia and
 fibrosis.Ultrasound-guided needle release of transverse carpal ligament(TCL) is an effective
 method to decompress the carpal.There are two main approaches to perform the release,
 short-axis or long-axis. However, there is no consensus about the optimal strategy.Thus, this
 study aimed to compare the efficacy of these two approaches for patients with
 mild-to-moderate CTS.

ICD-10 classifications
Carpal tunnel syndromeTarsal tunnel syndromeArthrosis of first carpometacarpal joint, unspecifiedArthrosis of first carpometacarpal jointOther specified disorders of synovium and tendon
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06251674
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06251674 through Pure Global AI's free database. This phase not specified trial is sponsored by Peking University People's Hospital and is currently Completed. The study focuses on Carpal Tunnel Syndrome. Target enrollment is 60 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.